Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DCH-036 | Astragaloside Ⅲ | >98%,Standard References | |
DCZ-102 | 20(R)-Notoginsenoside R2 | >98%,Standard References | |
DCS-085 | R-Notoginsenoside R2 | >98%,Standard References | |
DCL-055 | Roxithromycin | >98%,Standard References | |
DCP-008 | alpha-Viniferin | >98%,Standard References | |
DCF-004 | Sennoside B | >98%,Standard References | |
DCF-002 | Sennoside A | >98%,Standard References | |
DCG-004 | Glycyrrhizic acid Featured | >98%,Standard References | |
DCG-028 | Diammonium glycyrrhizinate | >98%,Standard References | |
DCZ-254 | Picfeltarraenin IB | >98%,Standard References | |
DCG-003 | Glycyrrhizic acid ammonium salt | >98%,Standard References | |
DCZ-040 | Chikusetsu saponin Ⅳa | >98%,Standard References | |
DCT-014 | Tenacissoside H | >98%,Standard References | |
DCS-056 | Esculentoside A | >98%,Standard References | |
DCZ-189 | Saikosaponin B1 | >98%,Standard References | |
DCC-024 | Saikosaponin A | >98%,Standard References | |
DCC-026 | Saikosaponin D | >98%,Standard References | |
DCC-051 | Saikosaponin B2 | >98%,Standard References | |
DCR-037 | 20(R)Ginsenoside Rg3 | >98%,Standard References | |
DCR-016 | Ginsenoside Rg2 | >98%,Standard References | |
DCR-038 | (S)Ginsenoside Rg2 | >98%,Standard References | |
DCR-027 | Ginsenoside F2 | >98%,Standard References | |
DCR-010 | Ginsenoside Rg3 | >98%,Standard References | |
DCR-015 | Ginsenoside Rg1 Featured | Ginsenoside Rg1 is one of the major active components of ginseng. Ginsenoside Rg1 displays promising effects by reducing cerebral Aβ levels. Ginsenoside Rg1 also reduces NF-κB nuclear translocation. | |
DCN-008 | Pseudoginsenoside F11 | >98%,Standard References | |
DCR-021 | Ginsenoside Rf | >98%,Standard References | |
DCJ-020 | 8-Gingerol | >98%,Standard References | |
DCC-067 | Theaflavine-3,3'-digallate | >98%,Standard References | |
DCM-040 | Dryocrassin ABBA | >98%,Standard References | |
DCL-048 | Wtlfordine | >98%,Standard References |